Clinical Trial Update: Caffeic Acid Tablets as a Second-line Therapy for ITP [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 trial evaluating caffeic acid tablets as a second-line therapy for immune thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Caffeic Acid Tablets (caffeic acid)

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia | Phase 3 | Status: COMPLETED